Literature DB >> 36185798

A case of hyperglycemic hyperosmolar syndrome in a pug dog.

Brittany Solomon1.   

Abstract

An 8-year-old spayed female pug dog that had recently been diagnosed with pancreatitis was brought to a veterinary clinic with polyuria, polydipsia, and seizures. The dog was diagnosed with hyperglycemic hyperosmolar syndrome, a rare complication of diabetes mellitus. The dog was hospitalized and was administered intravenous fluids and insulin therapy, and clinical signs improved. Copyright and/or publishing rights held by the Canadian Veterinary Medical Association.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36185798      PMCID: PMC9484192     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.075


  5 in total

Review 1.  Role of beta-hydroxybutyric acid in diabetic ketoacidosis: a review.

Authors:  Vladimir Stojanovic; Sherri Ihle
Journal:  Can Vet J       Date:  2011-04       Impact factor: 1.008

Review 2.  Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state.

Authors:  Jean-Louis Chiasson; Nahla Aris-Jilwan; Raphaël Bélanger; Sylvie Bertrand; Hugues Beauregard; Jean-Marie Ekoé; Hélène Fournier; Jana Havrankova
Journal:  CMAJ       Date:  2003-04-01       Impact factor: 8.262

3.  Can beta-hydroxybutyrate be detected at the bedside by in vitro oxidation with hydrogen peroxide.

Authors:  J R Oster; B Rietberg; A L Taylor; G O Perez; R Chandra; L B Gardner
Journal:  Diabetes Care       Date:  1984 Jan-Feb       Impact factor: 19.112

4.  Retrospective evaluation of hyperosmolar hyperglycemia in 66 dogs (1993-2008).

Authors:  Tara K Trotman; Kenneth J Drobatz; Rebecka S Hess
Journal:  J Vet Emerg Crit Care (San Antonio)       Date:  2013-09-19

5.  Bedside detection of urine beta-hydroxybutyrate in diagnosing metabolic acidosis.

Authors:  Silas W Smith; Alex F Manini; Tibor Szekely; Robert S Hoffman
Journal:  Acad Emerg Med       Date:  2008-07-11       Impact factor: 3.451

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.